Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMS (rTMS-AD)
Alzheimer's Disease
About this trial
This is an interventional treatment trial for Alzheimer's Disease focused on measuring Alzheimer's Disease, Brain stimulation, Transcranial Magnetic Stimulation, Neuroplasticity, cognitive enhancement, TMS-EEG, rTMS, PAS
Eligibility Criteria
Inclusion Criteria for AD participants:
- Age 55 years or above.
- Ability to understand and speak English.
- Confirmed Diagnosis of Probable AD by NIA-AA criteria.
- Either not taking Cognitive enhancers or taking them at a stable dose for the last 3 months.
- Willingness and ability to provide informed consent or an ability to assent and availability of a substitute decision maker willing to provide consent on participant's behalf.
- Corrected visual acuity enough to read newspaper headlines.
- Ability to hear a raised conversational voice, with hearing aids if needed.
Inclusion criteria for healthy control participants:
- Age 55 or above.
- Willingness and ability to speak English.
- Willingness and ability to provide informed consent.
- Corrected visual acuity enough to read newspaper headlines.
- Ability to hear a raised conversational voice, with hearing aids if needed.
Exclusion Criteria for AD participants:
- MOCA score < 10.
- DSM IV - TR diagnosis of a current episode of mood disorder in the last 3 months.
- DSM IV - TR diagnosis of a current anxiety disorder in the last 3 months.
- DSM IV - TR diagnosis of a current substance use disorder in the last 3 months.
- DSM IV - TR diagnosis of a current or lifetime primary psychotic disorder.
- Diagnosis of intellectual disability or a neurodevelopmental disorder.
- Electroconvulsive Therapy treatment in the last 6 months.
- History of a seizure other than a febrile seizure in infancy.
- Currently taking Anticonvulsants or Benzodiazepines.
- Any contraindication for TMS or any other medical condition/circumstances that would make the study participation difficult for the participant.
Exclusion criteria for healthy control participants:
- Meets criteria for a DSM IV - TR diagnosis other than simple phobias or Adjustment disorder.
- Any other neurological disorder affecting central nervous system.
- Psychotropic medication except for sedative /hypnotics at a stable dose for at least 4 weeks.
- History of seizure other than a febrile seizure in infancy
- Currently taking Anticonvulsants or Benzodiazepines.
- Any contraindication for TMS or any other medical condition/circumstances that would make the study participation difficult for the participant.
Sites / Locations
- Center for Addiction and Mental Health
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Sham Comparator
No Intervention
Alzheimer's disease rTMS
Alzheimer's disease rTMS Sham
Healthy Control
The intervention procedure done in this group is repetitive Transcranial Magnetic Stimulation.
The intervention procedure done in this group is Repetitive Transcranial Magnetic Stimulation - Sham
Healthy control group will only participate in baseline assessments which include baseline neuropsychological testing and baseline measurement of neuroplasticity. This will be used to standardize neuropsychological test scores and to compare the baseline neuroplasticity between healthy participants and Alzheimer's disease (AD) participants. Healthy control group will not get rTMS intervention.